Company intelligence / Profile preview

Rosetta Omics

Paris, Île-de-France, Francerosettaomics.fr ↗
Ownership
Private
Employees
~8
Development stage
Preclinical
01

Overview

Rosetta Omics has developed a patented platform that combines spatial multiomics profiling of tumor biopsies with advanced AI algorithms to deliver highly sensitive and specific predictions about optimal first-line therapies in oncology. Their solution is being validated clinically, starting with liver and colon cancers. The company collaborates closely with hospitals across France and Europe, as well as global partners in the USA, Singapore, and the Middle East. They are also developing companion diagnostics for patient stratification in clinical trials.[3][5]

Therapeutic areas
Oncology
Modalities
Multiomics-based diagnostics (spatial multiomics, deep mass spectrometry)AI-driven biomarker discovery and patient stratification tools
Industry
Molecular Diagnostics
02

Partnerships

Collaborations with pharmaceutical companies on biomarker discovery projects[3]Network of hospital partners across France/Europe; expanding globally to USA/Singapore/Middle East[5]

Beyond the preview

Go deeper on Rosetta Omics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosetta Omics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call